Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histiocytic Sarcoma | 2 | 2021 | 44 | 1.480 |
Why?
|
Hodgkin Disease | 8 | 2023 | 1413 | 0.980 |
Why?
|
Oximes | 1 | 2020 | 309 | 0.640 |
Why?
|
Preleukemia | 1 | 2017 | 35 | 0.630 |
Why?
|
Iris Diseases | 1 | 2017 | 40 | 0.610 |
Why?
|
Pyrimidinones | 1 | 2020 | 370 | 0.610 |
Why?
|
Pigmentation Disorders | 1 | 2017 | 101 | 0.590 |
Why?
|
Fetal Macrosomia | 1 | 2017 | 124 | 0.590 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 407 | 0.530 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2019 | 1515 | 0.520 |
Why?
|
Pyridones | 1 | 2020 | 712 | 0.510 |
Why?
|
Critical Pathways | 1 | 2019 | 475 | 0.510 |
Why?
|
Imidazoles | 1 | 2020 | 1205 | 0.460 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2028 | 0.450 |
Why?
|
Rhabdomyosarcoma, Embryonal | 4 | 2015 | 102 | 0.440 |
Why?
|
Sarcoma | 2 | 2021 | 1895 | 0.440 |
Why?
|
Burkitt Lymphoma | 2 | 2013 | 328 | 0.420 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1052 | 0.410 |
Why?
|
Rhabdomyosarcoma | 5 | 2014 | 382 | 0.400 |
Why?
|
Outpatients | 1 | 2019 | 1483 | 0.390 |
Why?
|
Mutation, Missense | 1 | 2020 | 2556 | 0.370 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 16 | 2021 | 11472 | 0.370 |
Why?
|
Inpatients | 1 | 2019 | 2495 | 0.300 |
Why?
|
Lymphatic Diseases | 1 | 2008 | 324 | 0.270 |
Why?
|
Lymphoproliferative Disorders | 2 | 2016 | 525 | 0.270 |
Why?
|
Radiotherapy, Conformal | 2 | 2011 | 548 | 0.260 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2010 | 475 | 0.260 |
Why?
|
Orbital Neoplasms | 2 | 2005 | 225 | 0.250 |
Why?
|
Germinoma | 1 | 2003 | 133 | 0.210 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 3497 | 0.210 |
Why?
|
Mediastinum | 1 | 2003 | 267 | 0.200 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.200 |
Why?
|
Child, Preschool | 20 | 2021 | 40955 | 0.190 |
Why?
|
Lymphatic Irradiation | 1 | 2021 | 104 | 0.190 |
Why?
|
Medical Order Entry Systems | 1 | 2006 | 544 | 0.180 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2016 | 569 | 0.180 |
Why?
|
Mediastinal Neoplasms | 1 | 2003 | 421 | 0.180 |
Why?
|
Trisomy | 1 | 2021 | 266 | 0.180 |
Why?
|
Herpesvirus 4, Human | 2 | 2021 | 1040 | 0.180 |
Why?
|
Child | 27 | 2023 | 77478 | 0.170 |
Why?
|
Jaundice | 1 | 2019 | 89 | 0.170 |
Why?
|
Hospitalization | 1 | 2019 | 10232 | 0.170 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 222 | 0.170 |
Why?
|
Platelet Count | 1 | 2002 | 780 | 0.170 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2021 | 345 | 0.170 |
Why?
|
Fever of Unknown Origin | 1 | 2019 | 93 | 0.160 |
Why?
|
Platelet Transfusion | 1 | 2002 | 314 | 0.160 |
Why?
|
Drug Substitution | 1 | 2021 | 281 | 0.160 |
Why?
|
Disease-Free Survival | 7 | 2021 | 6891 | 0.160 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2014 | 806 | 0.150 |
Why?
|
Sarcoma, Myeloid | 1 | 2018 | 59 | 0.150 |
Why?
|
Exophthalmos | 1 | 2018 | 96 | 0.150 |
Why?
|
Skull Neoplasms | 1 | 2018 | 173 | 0.150 |
Why?
|
Sphenoid Bone | 1 | 2018 | 172 | 0.150 |
Why?
|
Adolescent | 21 | 2021 | 85649 | 0.140 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1998 | 142 | 0.140 |
Why?
|
Lymph Nodes | 4 | 2021 | 3465 | 0.140 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1379 | 0.140 |
Why?
|
Blood Cell Count | 3 | 2019 | 402 | 0.140 |
Why?
|
Biopsy | 5 | 2012 | 6756 | 0.140 |
Why?
|
Dacryocystitis | 1 | 2016 | 69 | 0.130 |
Why?
|
Meningeal Neoplasms | 3 | 2015 | 1241 | 0.130 |
Why?
|
Gynecomastia | 1 | 2016 | 88 | 0.130 |
Why?
|
Lymphoma | 2 | 2021 | 1873 | 0.130 |
Why?
|
Dyskeratosis Congenita | 1 | 2015 | 72 | 0.130 |
Why?
|
Lymphoma, B-Cell | 1 | 2002 | 930 | 0.130 |
Why?
|
Fever | 3 | 2018 | 1612 | 0.130 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1792 | 0.130 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2015 | 55 | 0.130 |
Why?
|
Male | 36 | 2021 | 349538 | 0.120 |
Why?
|
Infant | 12 | 2021 | 35070 | 0.120 |
Why?
|
Medical Oncology | 1 | 2006 | 2235 | 0.120 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2018 | 600 | 0.120 |
Why?
|
Thrombocytopenia | 1 | 2002 | 1171 | 0.120 |
Why?
|
Combined Modality Therapy | 7 | 2019 | 8621 | 0.120 |
Why?
|
Immunoglobulin M | 1 | 1998 | 1538 | 0.110 |
Why?
|
Humans | 46 | 2023 | 742088 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1581 | 0.110 |
Why?
|
Pancreatic Neoplasms | 1 | 2010 | 5249 | 0.110 |
Why?
|
Nasal Cavity | 1 | 2015 | 312 | 0.110 |
Why?
|
Diagnosis, Differential | 8 | 2019 | 12958 | 0.110 |
Why?
|
Nose Neoplasms | 1 | 2015 | 245 | 0.110 |
Why?
|
Medulloblastoma | 1 | 2018 | 681 | 0.110 |
Why?
|
Pelvic Neoplasms | 1 | 2014 | 254 | 0.110 |
Why?
|
Thoracic Neoplasms | 1 | 2014 | 268 | 0.100 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2015 | 546 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2107 | 0.100 |
Why?
|
Organs at Risk | 2 | 2011 | 346 | 0.100 |
Why?
|
Appendiceal Neoplasms | 1 | 2013 | 145 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2002 | 2117 | 0.090 |
Why?
|
Neoplasms | 4 | 2023 | 21596 | 0.090 |
Why?
|
Whole Body Imaging | 1 | 2012 | 280 | 0.090 |
Why?
|
Melanoma | 2 | 2019 | 5462 | 0.090 |
Why?
|
Autoantibodies | 1 | 1998 | 2036 | 0.090 |
Why?
|
Hemorrhage | 1 | 2002 | 3461 | 0.090 |
Why?
|
Fractures, Compression | 1 | 2011 | 134 | 0.080 |
Why?
|
Skin Neoplasms | 2 | 2019 | 5662 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1901 | 0.080 |
Why?
|
Radiotherapy Dosage | 5 | 2015 | 2876 | 0.080 |
Why?
|
Hypercalcemia | 1 | 2011 | 405 | 0.080 |
Why?
|
Doxorubicin | 4 | 2015 | 2215 | 0.080 |
Why?
|
Female | 25 | 2021 | 379592 | 0.080 |
Why?
|
Lumbar Vertebrae | 2 | 2011 | 1844 | 0.080 |
Why?
|
Crohn Disease | 1 | 2021 | 2301 | 0.080 |
Why?
|
Blood Sedimentation | 1 | 2008 | 231 | 0.070 |
Why?
|
Treatment Outcome | 13 | 2021 | 62966 | 0.070 |
Why?
|
Lymphadenitis | 1 | 2008 | 98 | 0.070 |
Why?
|
Breast | 1 | 2016 | 1958 | 0.070 |
Why?
|
Vincristine | 2 | 2015 | 1036 | 0.070 |
Why?
|
Photons | 2 | 2011 | 587 | 0.070 |
Why?
|
Prednisone | 3 | 2012 | 1567 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2522 | 0.070 |
Why?
|
Cyclophosphamide | 3 | 2015 | 2236 | 0.070 |
Why?
|
Organizational Case Studies | 1 | 2006 | 299 | 0.060 |
Why?
|
Radiotherapy | 3 | 2011 | 1525 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 6 | 2018 | 20086 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2374 | 0.060 |
Why?
|
Spinal Fractures | 1 | 2011 | 698 | 0.060 |
Why?
|
Back Pain | 2 | 2011 | 545 | 0.060 |
Why?
|
Radiography | 3 | 2011 | 7010 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2015 | 1769 | 0.060 |
Why?
|
Neuroblastoma | 1 | 2011 | 1225 | 0.060 |
Why?
|
Radiotherapy, High-Energy | 1 | 2004 | 228 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5425 | 0.060 |
Why?
|
Pediatrics | 1 | 2018 | 3462 | 0.060 |
Why?
|
Survival Rate | 2 | 2018 | 12773 | 0.060 |
Why?
|
Mastitis, Bovine | 1 | 2002 | 11 | 0.050 |
Why?
|
Protons | 3 | 2014 | 1126 | 0.050 |
Why?
|
Phenylbutyrates | 1 | 2002 | 69 | 0.050 |
Why?
|
Neoplasm, Residual | 2 | 2021 | 974 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3471 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39004 | 0.050 |
Why?
|
Hospitals, General | 1 | 2006 | 749 | 0.050 |
Why?
|
Leukopenia | 1 | 2002 | 208 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8333 | 0.050 |
Why?
|
Uremia | 1 | 2002 | 200 | 0.050 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2015 | 1622 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2712 | 0.050 |
Why?
|
Streptococcus agalactiae | 1 | 2002 | 375 | 0.050 |
Why?
|
Fetal Hemoglobin | 1 | 2002 | 341 | 0.050 |
Why?
|
Liver | 1 | 2015 | 7470 | 0.040 |
Why?
|
Mutation | 2 | 2021 | 29717 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2002 | 15244 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2019 | 157 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
Milk | 1 | 2002 | 449 | 0.040 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2013 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2023 | 596 | 0.040 |
Why?
|
Serum Albumin | 1 | 2002 | 674 | 0.040 |
Why?
|
Leukemia, Myeloid | 1 | 2002 | 705 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2018 | 35342 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2018 | 77098 | 0.040 |
Why?
|
Abdominal Pain | 2 | 2016 | 1059 | 0.040 |
Why?
|
Leg | 1 | 2003 | 1110 | 0.040 |
Why?
|
Streptococcal Infections | 1 | 2002 | 637 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2010 | 2229 | 0.040 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2003 | 484 | 0.040 |
Why?
|
Prognosis | 4 | 2023 | 29010 | 0.040 |
Why?
|
Tumor Burden | 2 | 2015 | 1905 | 0.040 |
Why?
|
Vinblastine | 2 | 2012 | 490 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 56350 | 0.040 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1465 | 0.040 |
Why?
|
Massachusetts | 2 | 2011 | 8662 | 0.040 |
Why?
|
Chromosome Disorders | 1 | 2000 | 515 | 0.040 |
Why?
|
Disease Progression | 3 | 2021 | 13256 | 0.040 |
Why?
|
Pallor | 1 | 2016 | 5 | 0.040 |
Why?
|
Age Factors | 3 | 2018 | 18355 | 0.040 |
Why?
|
Cholestasis | 1 | 2019 | 378 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 1998 | 343 | 0.030 |
Why?
|
Adult | 7 | 2019 | 213712 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2000 | 1583 | 0.030 |
Why?
|
Cyclosporine | 1 | 1998 | 784 | 0.030 |
Why?
|
Topotecan | 1 | 2015 | 138 | 0.030 |
Why?
|
Bacteremia | 1 | 2002 | 962 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3527 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2002 | 15056 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9185 | 0.030 |
Why?
|
Anemia, Sickle Cell | 1 | 2002 | 1017 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2019 | 701 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2000 | 1179 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 528 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3266 | 0.030 |
Why?
|
Ultrasonography, Mammary | 1 | 2016 | 250 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 1998 | 657 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2012 | 11001 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2763 | 0.030 |
Why?
|
Fatal Outcome | 1 | 1998 | 1849 | 0.030 |
Why?
|
Etoposide | 1 | 2015 | 637 | 0.030 |
Why?
|
Spleen | 1 | 2019 | 2359 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2000 | 1811 | 0.030 |
Why?
|
Colon, Sigmoid | 1 | 2013 | 118 | 0.030 |
Why?
|
Brain | 3 | 2015 | 26343 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1927 | 0.030 |
Why?
|
Mesentery | 1 | 2013 | 205 | 0.030 |
Why?
|
Methotrexate | 2 | 2012 | 1720 | 0.030 |
Why?
|
Syndrome | 1 | 1998 | 3248 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3164 | 0.030 |
Why?
|
Regression Analysis | 1 | 2002 | 6452 | 0.030 |
Why?
|
Blood Transfusion | 1 | 1998 | 1296 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6259 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2019 | 2513 | 0.030 |
Why?
|
Prospective Studies | 4 | 2021 | 53187 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4554 | 0.020 |
Why?
|
Acute Disease | 1 | 2002 | 7141 | 0.020 |
Why?
|
Rhabdomyosarcoma, Alveolar | 1 | 2011 | 41 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3256 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2575 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2723 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2002 | 1820 | 0.020 |
Why?
|
Abdomen | 1 | 2016 | 1107 | 0.020 |
Why?
|
Risk Factors | 3 | 2021 | 72145 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2013 | 537 | 0.020 |
Why?
|
Telomere | 1 | 2015 | 909 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2008 | 7153 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1998 | 1847 | 0.020 |
Why?
|
Risk | 1 | 2002 | 9679 | 0.020 |
Why?
|
Nausea | 1 | 2012 | 665 | 0.020 |
Why?
|
Survival Analysis | 1 | 2002 | 10248 | 0.020 |
Why?
|
Radiometry | 1 | 2014 | 800 | 0.020 |
Why?
|
Odds Ratio | 1 | 2002 | 9846 | 0.020 |
Why?
|
Bradycardia | 1 | 2011 | 305 | 0.020 |
Why?
|
Vomiting | 1 | 2012 | 632 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2615 | 0.020 |
Why?
|
Estrogens | 1 | 2016 | 1562 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5975 | 0.020 |
Why?
|
Cisplatin | 1 | 2015 | 1637 | 0.020 |
Why?
|
Growth Plate | 1 | 2010 | 274 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2016 | 20774 | 0.020 |
Why?
|
Pulmonary Blastoma | 1 | 2008 | 33 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1653 | 0.020 |
Why?
|
Femur Head | 1 | 2010 | 301 | 0.020 |
Why?
|
Pelvic Bones | 1 | 2010 | 265 | 0.020 |
Why?
|
Celiac Disease | 1 | 2016 | 785 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12242 | 0.020 |
Why?
|
Pedigree | 1 | 2015 | 4646 | 0.020 |
Why?
|
Pain | 1 | 2003 | 4961 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11039 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2015 | 1178 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 40450 | 0.020 |
Why?
|
Neutropenia | 1 | 2012 | 891 | 0.020 |
Why?
|
Peritoneal Neoplasms | 1 | 2013 | 663 | 0.020 |
Why?
|
Testis | 1 | 2010 | 800 | 0.020 |
Why?
|
Bone Diseases, Metabolic | 1 | 2011 | 417 | 0.020 |
Why?
|
Anemia | 1 | 2016 | 1499 | 0.020 |
Why?
|
Appendicitis | 1 | 2013 | 644 | 0.020 |
Why?
|
Neuralgia | 1 | 2012 | 568 | 0.020 |
Why?
|
Decision Making | 1 | 2000 | 3869 | 0.020 |
Why?
|
Time Factors | 3 | 2021 | 40054 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3691 | 0.020 |
Why?
|
Testosterone | 1 | 2016 | 2401 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 1998 | 4147 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 2906 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5692 | 0.020 |
Why?
|
Procarbazine | 1 | 2004 | 181 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3528 | 0.020 |
Why?
|
Parents | 1 | 2018 | 3387 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3766 | 0.020 |
Why?
|
Thoracic Surgical Procedures | 1 | 2008 | 341 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6534 | 0.010 |
Why?
|
Urinary Bladder | 1 | 2010 | 1171 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2008 | 13019 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1255 | 0.010 |
Why?
|
Risk Assessment | 2 | 2021 | 23320 | 0.010 |
Why?
|
Immunotherapy | 1 | 2019 | 4414 | 0.010 |
Why?
|
Ultrasonography | 1 | 2016 | 5978 | 0.010 |
Why?
|
Aged | 2 | 2008 | 162944 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 4839 | 0.010 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2016 | 2410 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 3336 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2542 | 0.010 |
Why?
|
Middle Aged | 2 | 2008 | 213127 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12344 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2000 | 25575 | 0.010 |
Why?
|
United States | 2 | 2021 | 69693 | 0.010 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2002 | 947 | 0.010 |
Why?
|
Defective Viruses | 1 | 1978 | 112 | 0.010 |
Why?
|
DNA, Circular | 1 | 1978 | 96 | 0.010 |
Why?
|
DNA Primers | 1 | 2002 | 2892 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 2002 | 814 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 12730 | 0.010 |
Why?
|
Pneumonia | 1 | 2008 | 2117 | 0.010 |
Why?
|
Cattle | 1 | 2002 | 3923 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13655 | 0.010 |
Why?
|
Administration, Oral | 1 | 2002 | 3913 | 0.010 |
Why?
|
Simplexvirus | 1 | 1978 | 802 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11363 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8829 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6171 | 0.010 |
Why?
|
Patient Compliance | 1 | 2002 | 2680 | 0.010 |
Why?
|
DNA, Viral | 1 | 1978 | 2224 | 0.010 |
Why?
|
Base Sequence | 1 | 2002 | 12797 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10943 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14720 | 0.000 |
Why?
|
Molecular Weight | 1 | 1978 | 2255 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1978 | 2645 | 0.000 |
Why?
|
Virus Replication | 1 | 1978 | 2531 | 0.000 |
Why?
|
Animals | 1 | 2002 | 168561 | 0.000 |
Why?
|
Cell Nucleus | 1 | 1978 | 2968 | 0.000 |
Why?
|
Cell Line | 1 | 1978 | 15994 | 0.000 |
Why?
|